Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9618880 | 0.84 | LMNA (0.39) | RAB9ALMNAHTTALDH1A1KMT2A | |
| SCHEMBL31547606 | 0.73 | — | — | |
| SCHEMBL2791561 | 0.73 | — | — | |
| SCHEMBL8442476 | 0.72 | LMNA (0.35) | RAB9ALMNAHTTALDH1A1KMT2A | |
| Hydrochloric Acid SCHEMBL9313820 | 0.71 | LMNA (0.41) | RAB9ALMNAHTTALDH1A1CA12 | |
| SCHEMBL28531618 | 0.71 | LMNA (0.41) | RAB9ALMNAHTTALDH1A1CA12 | |
| SCHEMBL9730683 | 0.70 | ABCB1 (0.39) | LMNAHTTALDH1A1KMT2ASLC2A1 | |
| SCHEMBL27832671 | 0.70 | MCHR1 (0.37) | RAB9ALMNAHTTALDH1A1KMT2A | |
| SCHEMBL9730680 | 0.70 | ABCB1 (0.39) | LMNAHTTALDH1A1KMT2ASLC2A1 | |
| SCHEMBL15901319 | 0.70 | HPGD (0.40) | RAB9ALMNACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250387384-A1 | ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS | ZEVRA DENMARK AS (DK) | 2025-12-25 | — | — | US | claimed |
| WO-2009068194-A2 | HALOGEN-SUBSTITUTED Δ1 PYRROLINES | BAYER CROPSCIENCE AG (DE) | 2009-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387384-A1 | ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS | GBA1, GBA2, SNCA | RAB9A 31/4885LMNA 592/4885HTT 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.